AI Companion
AI Health Assistant
LeoNex AI
Context-aware · RAG over your protocols
Compound Database
Semaglutide
GLP-1t½ 165h · 0.25–2.4 mg / week
GLP-1 receptor agonist studied for appetite regulation and glycemic control. Long half-life supports once-weekly dosing.
Tirzepatide
GLP-1t½ 120h · 2.5–15 mg / week
Dual GIP/GLP-1 receptor agonist investigated for weight management and metabolic markers.
BPC-157
Recoveryt½ 4h · 250–500 mcg / day
Gastric-derived peptide studied for tendon, ligament and gut healing in animal models.
TB-500 (Thymosin β4)
Recoveryt½ 6h · 2–5 mg / week
Synthetic fragment of thymosin beta-4 explored for tissue repair and inflammation modulation.
CJC-1295 / Ipamorelin
GH Secretagoguet½ 30h · 300 mcg / day before bed
Growth hormone secretagogue combination studied for sleep quality and recovery.
Tesamorelin
GH Secretagoguet½ 26h · 1–2 mg / day
GHRH analog investigated for visceral fat reduction and metabolic health.
Melanotan II
Cosmetict½ 2h · 250–500 mcg / day
Melanocortin agonist studied for pigmentation response. Notable side-effect profile.
GHK-Cu
Anti-agingt½ 5h · 1–3 mg / day
Copper-binding peptide studied for skin repair, collagen stimulation and wound healing.
MOTS-c
Metabolict½ 8h · 5–10 mg / week
Mitochondrial-derived peptide investigated for exercise capacity and metabolic regulation.
Epitalon
Anti-agingt½ 3h · 5–10 mg / cycle
Pineal peptide studied for telomerase activity and circadian regulation in animal models.
AI Protocol Builder
Answer a few questions and the AI suggests a research stack based on your goals.